Iridian Asset Management LLC Avadel Pharmaceuticals PLC Transaction History
Iridian Asset Management LLC
- $359 Million
- Q4 2024
Shares
13 transactions
Others Institutions Holding AVDL
# of Institutions
6Shares Held
738KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL600KShares$5.17 Million4.07% of portfolio
-
Schulhoff & CO Inc137KShares$1.18 Million0.67% of portfolio
-
American Portfolios Advisors Holbrook, NY500Shares$4,3100.0% of portfolio
-
American Research & Management Co.100Shares$8610.0% of portfolio
-
Exane Derivatives33Shares$2840.0% of portfolio
About AVADEL PHARMACEUTICALS PLC
- Ticker AVDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 60,581,300
- Market Cap $522M
- Description
- Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...